Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus
Poor blood sugar control can lead to additional complications, including cardiovascular disease, for which people with lupus are already at higher risk
Can I stil use Ozempic or other GLP-1 medications if Im at risk for gastroparesis
Moreover, a large-scale randomized controlled trial (RCTs) involving more than 17,000 individuals with obesity and cardiovascular disease demonstrated that semaglutide reduced the risk of cardiovascular death, myocardial infarction (MI), and stroke compared to the placebo 9
Refer to our real-time map for current updates
Semaglutide has transformed weight loss treatment by activating GLP-1 receptors in the brain and gut, reducing appetite and improving metabolic control